Mebane Medical Clinic Pa Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1242- C South Fifth Street, Mebane, NC 27302 Phone: 919-563-3007 Fax: 919-563-1993 |
Kernodle Clinic-mebane Internal Medicine - Endocrinology, Diabetes & Metabolism Medicare: Medicare Enrolled Practice Location: 101 Medical Park Dr, Mebane, NC 27302 Phone: 919-563-2500 |
Mebane Medical Clinic Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 3940 Arrowhead Blvd, Suite 225, Mebane, NC 27302 Phone: 919-563-3007 Fax: 919-563-1993 |
Mebane Primary Care Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 100 E Dogwood Dr, Mebane, NC 27302 Phone: 919-563-2896 |
Unc Primary Care At Mebane Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 100 E Dogwood Dr, Mebane, NC 27302 Phone: 919-563-2896 Fax: 919-563-2724 |
Bliss Medical Group Pa Family Medicine Medicare: Medicare Enrolled Practice Location: 132 Millstead Dr, Mebane, NC 27302 Phone: 919-563-4444 Fax: 919-563-4442 |
Duke Primary Care Mebane Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1352 Mebane Oaks Rd, Mebane, NC 27302 Phone: 919-563-8400 Fax: 919-563-8453 |
Duke University Affiliated Physicians, Inc Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 100 E Dogwood Dr, Mebane, NC 27302 Phone: 919-563-8400 |
News Archive
In the context of sociological research, cancer patients' quality of life and living conditions constitute their welfare.
A common compound known to fight lymphoma and skin conditions actually has a second method of action that makes it particularly deadly against certain aggressive breast tumors, researchers at Duke Medicine report.
A study co-published in Nature Medicine this week by University of Toronto researcher Penney Gilbert has determined a stem cell based method for restoring strength to damaged skeletal muscles of the elderly.
The National Comprehensive Cancer Network has been awarded a $2.1 million grant from Pfizer to develop a program to scientifically evaluate and define the clinical activity of axitinib in various tumor types.
Last week an Indian patent court shocked the $600 billion global pharmaceutical business by ordering Bayer, the German health care giant, to allow a tiny Indian generic drug company to sell cheap copies of the blockbuster cancer drug Nexavar – even though everyone agrees that the drug is protected by a patent. Instead, the court decided that Bayer had an obligation to make Nexavar available to people in India who needed it.
› Verified 8 days ago